Difference and alteration in pharmacokinetic and metabolic characteristics of low-solubility natural medicines
Author:
Affiliation:
1. Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing, PR China;
2. School of Pharmaceutical Science, Guangxi University of Chinese Medicine, Nanning, PR China
Funder
National Natural Science Foundation of China
Chongqing Science and Technology Commission
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Link
https://www.tandfonline.com/doi/pdf/10.1080/03602532.2018.1430823
Reference80 articles.
1. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia
2. Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial
3. Agglomerated Oral Dosage Forms of Artemisinin/β-Cyclodextrin Spray-Dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability
4. Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria
5. Paclitaxel-loaded niosomes for intravenous administration: pharmacokineticsand tissue distribution in rats
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Uptake, tissue distribution, and biotransformation pattern of triclosan in tilapia exposed to environmentally-relevant concentrations;Science of The Total Environment;2024-04
2. Deciphering resveratrol's role in modulating pathological pain: From molecular mechanisms to clinical relevance;Phytotherapy Research;2023-10-05
3. Novel Natural Carrier‐Free Self‐Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier;Advanced Healthcare Materials;2023-09-19
4. Pharmacokinetic and safety profile of PT109B, a novel multi-targeted compound against Alzheimer's disease;European Journal of Pharmaceutical Sciences;2023-09
5. Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers;Cell Biology and Toxicology;2022-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3